Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer

British Journal of Urology

Volumn 77, Issue 1, 1996, Pages 61-69

  Iles, R K ^a   Persad, R ^a   Trivedi, M ^a   Sharma, K B ^a   Dickinson, A ^a   Smith, P ^a   Chard, T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bladder cancer; Creatinine; Metastasis; Prognostic factor; Urinary beta human chorionic gonadotrophin

Indexed keywords

CHORIONIC GONADOTROPIN; CREATININE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER PROGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; URINE LEVEL;

EID: 0030033551     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.82910.x     Document Type: Article

References (34)

1. Petersen RO. Urologie Pathology. Philadelphia: JB Lippincott. 1986: 325-60
2. Morrison AS. Cole P, Maclure KM. Epidemiology of urologie cancers. In Javadpour N ed. Principles and Management of Urologie Cancer, 2nd edn. Baltimore: Williams & Wilkins, 1983: 13-32
3. Kenny GM, Hardener GJ, Murphy GP. Clinical staging of bladder tumours. J Ural 1970; 104: 720-3
4. Schmidt JD. Weinstein SH. Pitfalls in clinical staging of bladder tumours. Urol Clin North Am 1976; 3: 107-27
5. Russell PJ, Wills EJ. Phillips J et al. Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma; evidence of a common histogenesis? Urol Res 1986: 16: 79-84
6. Blomjous CE. Schipper NW. Vos W. Baak JP. de Voogt H], Meijer CJ. Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flowcytometric, nuclear morphometric and clinico-pathological features. Virchows Archiv A Pathol Anat Histopathol 1989: 415: 421-8
7. Bergman S. Javadpour N. The cell surface antigen A. B or 0(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. J Urol 1978; 119: 49-51
8. Fujita J. Matsumoto K. Ishiyama I. Synthesis of ABH blood group substances in bladder tumours. Br J Urol 1981: 53: 448-52
9. Nakatsu H. Kobayashi I, Onishi Y et al. ABO(H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder. J Urol 1987: 138: 1329-35
10. Messing EM. Hanson P. Urlich P. Erturk E. Epidermal growth factor -interaction with normal and malignant urothelium; in vivo and in situ studies. J Urol 1987: 138: 252-7
11. Neal DE. Smith K, Fennelly JA. Bennett MK, Hall RR, Harris AL. Epidermal growth factor receptor in bladder cancer: a comparison of immunohistochemistry and ligand binding. J Urol 1989; 141: 517-21
12. Smith K. Fennelly JA, Neal DE. Hall RR. Harris AL. Characterization of the epidermal growth factor receptor in invasive and superficial bladder tumours. Cancer Res 1989:49: 5810-5
13. 3 Guirguis R, Schiffman E, Liu B. Birkbeck D, Engel J, Liotta L. Detection of autocrine motility factor in urine as a marker of bladder cancer. J Natl Cancer Inst 1988: 80: 1203-11
14. Blomjous CE. Vos W. De Voogt HJ. Van der Valk P. Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic. morphometric and ultrastructural study of 18 cases. Cancer 1989: 64: 1 347-57
15. lies RK, Chard T. Review: human chorionic gonadotropin expression by bladder cancers; biology and clinical potential. J Urol 1991: 145: 453-8
16. Martin JE, Jenkins BJ. Zuk RJ, Oliver RTD. Baithun SI. Human chorionic gonadotropin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virchows Archiv A Pathol Anal Histopathol 1989: 414: 273-7
17. Jacobsen A-B, Nesland JM, Fossa SD. Pettersen EO. Human chorionic gonadotropin. neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma. J Urol 1990: 143: 706-9
18. Fossa SD, Berner AA. Jacobsen A-B et al. Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein. c-erbB-2 protein and HCG in operable muscle invasive bladder cancer. Br J Cancer 1993: 67: 572-8
19. Smith DJ, Evans HJ, Newman J. Chappie CR. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder? Br ] Urol 1994: 73: 409-12
20. lies RK. Chard T. Review: molecular insights into the structure and function of human chorionic gonadotrophin. J Mol Endocrinol 1993; 10: 217-34
21. Handwerger S, Wilson SP, Tyrey L, Conn PM. Biochemical evidence that human placental lactogen and human chorionic gonadotropin are not stored in cytoplasmic secretion granules. Biol Reprod 1987; 37: 28-32
22. Corless CL. Matzuk MM. Ramabhadram TV. Krichevsky A, Boime 1. Gonadotropin beta-subunits determine the rate of assembly and the oligosaccharide processing of hormone dimer in transfected cells. J Cell Biol 1987; 104: 1173-81
23. Wurzel RS. Yamase HT, Nieh PT. Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract. J Urol 1987: 137: 502-4
24. lies RK, Jenkins BJ, Oliver RTD. Blandy JP, Chard T. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol 1989: 64: 241-4
25. Marcilliac I, Troalen F, Bidart J-M et al Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992; 52: 3901-7
26. Marcilliac I, Cottu P. Theodore C, Tcrrier-Lacombc M-J. Bellet D, Droz J-P. Free hCG-beta subunit as tumour marker in urothelial cancer. Lancet 1993; 341: 1354-5
27. Nisula BC, Blithe DL. Akar A. Lefort G. Wehmann RE. Metabolic fate of human choriogonadotropin. J Steroid Biochem 1989; 33: 733-7
28. Norman Rf. Lowings C. Oliver T, Chard T. Human chorionic gonadotrophin and its subunits -heterogeneity in serum of male patients with tumours of the genital tract. Clin Endocrinol 1985; 23: 25-34
29. Iles RK. Beta Human Chorionic Gomulutropliin Production by Kindlier Tumour Cells: Incidence. Molecular Analysis and Clinical Significance. PhD Thesis. I'K: University of London. 1991: 102-50
30. Latblie P. Beck O. Blennow G et ni. Importance of creatinine analyses of urine when screening lor abused drugs. Clin Chem 1991: 37: 1927-51
31. Martin |K. Jcnkins BJ. Zuk RJ. Blandy Baithun SI. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Path 1989: 42: 250-5
32. (enkins BJ. Martin JE, Baithun SI. Xuk R. Oliver RTD. Blandy JP. Prediction of response to radiotherapy in invasive bladder cancer. Br J Ural 1990: 65: 545-8
33. 5 Moutzouris (!. Yannopoulos D. Barbatis C. Zaharof A. Theodorou CH. Is beta human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy? Kr I Uivl 1995: 72: 907-9
34. Smith |A. YVhitmore JR. Regional lymph node métastases from bladder cancer. J Ural 1981: 126: S81-93